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Introduction
Nanocarriers are nanomaterial scale assemblies that can easily circulate
in-vivo and can be modified to carry a hydrophobic and hydrophilic drug
molecules, and shows controlled release. Of such nanocarrier
mesoporous silica nanoparticles (MSNPs) stand out due to their many
distinct features such as large network of pores and the large surface to
volume ratio that they offer. MSNPs were used carry a small molecule
antibiotic isoniazid (INH) to specifically target the surface of
Mycobacteria. We have used plant lectins such as Concanavalin A
(CONA) and Aleuria aurantia lectins (AAL) to specifically target the cell
surface of Mycobacteria. Once the MSNP binds to the cell surface INH is
released to the local environment around the bacteria.

Antibacterial Assays - Mycobacterium smegmatis (Msmeg) was grown to a
absorbance of 0.5 (105 CFU/mL), 10 µL was incubated at 37 oC overnight with,
20 µL of varying concentrations (1 µg/mL - 1 mg/mL) of nanoparticles. The
following day 20 µLof the incubated solution was incubated with 10 µL of water
soluble tetrazolium (WST-8) reagent and 170 µL of Mueller Hinton broth for 2
hours at 37 oC. After incubation the absorbance was recorded at 650 nm.
Determining Antibacterial Activity - The antibacterial activity of the particles
were determined by the results of WST-8 assay. The absorbance at 650 nm
was compared to the control of live untreated bacteria to determine percentage
(%) viability.

Results and Discussion

Scheme 1. Synthesis of lectin conjugated
isoniazid (INH) loaded mesoporous silica
nanoparticles (MSNP-INH-Lectin)

Particles

Diameter (nm)

Zeta Potential (mV)

Concentration (mg/mL)

MSNP

492.7 nm

-40.8

0.8 mg/mL

MSNP-INH

763.6 nm

12.8

1.4 mg/mL

MSNP-PEG-NHS

432 nm

-26.2

1.1 mg/mL

MSNP-CONA

441.2 nm

-39.3

1.2 mg/mL

MSNP-BSA

413.1 nm

-34.0

2.7 mg/mL

MSNP-AAL

401.7 nm

-34.3

1.3 mg/mL

MSNP-PAB

391.1 nm

-32.0

2.0 mg/mL

MSNP-WFL

365.3 nm

-33.8

0.9 mg/mL

MSNP-INH-CONA

637.3 nm

26.4

2.7 mg/mL

Table 1. The diameter and zeta potential was measured for all synthesized mesoporous silica particles
(MSNs).

Materials and Methods
MSNP Synthesis - 204 mg of Cetrimonium bromide (0.00056 mol) were
mixed with 140 mL of filtered water and allowed to stir. 1.688 mL of
tetraethyl orthosilicate (TEOS, 0.008 mol) was added dropwise to the
mixture. 1.688 mL of ammonium hydroxide (NH4OH, 0.043 mol) was
additionally added to the mixture and added dropwise. The solution was
allowed to stir overnight. The next day, the solution was centrifuged at 7830
rpm for 10 minutes. The supernatant was removed, and 15 mL of water was
added to the precipitate. The solution was sonicated and added to a round
bottom flask. 100 mL of ethanol (1.714 mol) was added to the solution.
Additionally, 0.2 mL of hydrochloric acid (HCl, 0.0065 mol) was added to the
solution. The solution was heated at 60℃ and stirred at 400 rpm overnight.
The next day, the solution was centrifuged for 10 minutes at 7830 rpm. The
supernatant was removed, and 15 mL of water was added to the
precipitate. The solution was sonicated, and the solution was centrifuged for
10 minutes at 7830 rpm. This step was repeated. Once the final solution
was prepared, the zeta and size were measured.
MSNP-INH Synthesis - After the purification of the MSNP, 10 mg of
isoniazid (INH) was dissolved in 5 mL of filtered water. This mixture was
added to the MSNP solution. Afterwards, 60 µL of a diluted Hydrochloric
acid ( 1 mL Hydrochloric acid 9 mL water) was added to the solution. The
solution was allowed to stir overnight. The next day the mixture was
centrifuged at 7830 rpm for 10 minutes. After being the centrifuged, the
size, zeta, and concentration of the solution was measured.
MSNP-PEG-NHS Synthesis - After the purification of the MSNP, 1 mg of
the ligand NHS-PEG-Silane (0.0002 mol) was added to the solution of
MSNP and, it was allowed to stir overnight. The next day the mixture was
centrifuged at 7830 rpm for 10 minutes. After being the centrifuged, the
size, zeta, and concentration of the solution was measured.
MSNP-Protein Synthesis - After the addition of the ligand (NHS-PEGSilane) 1 mg of the protein (lectin and non-lectin) being tested (CON A,
bovine serum albumin (BSA), AAL, polyclonal antibody (PAB), or Wisteria
floribunda lectin (WFL) was added to the MSNP solution. The solution was
allowed to stir overnight. The next day the mixture was centrifuged at 7830
rpm for 10 minutes. After being the centrifuged, the size, zeta, and
concentration of the solution was measured.
Characterization - Size (diameter) of the spherical particles were
measured using dynamic light scattering (DLS, Malvern NanoZS). The
surface charge was measure using zeta potential. Particles were imaged
using transmission electron microscope (TEM, 200 kV FEI Tecnai Osiris)

MSNPs are negatively charged as can be seen with the zeta potential of -40
mV. But as the surface is conjugated with proteins and antibiotics the surface
charge has changed to +26 mV.

Figure 1. Transmission electron microscopy image of (left) mesoporous nanoparticles
(MSNPs). (right) image magnified to show the porous network of MSNPs.

Porosity of MSNPs measured by Brunauer–Emmett–Teller method. Total
pore volume was found to be 2.4 cm3/g and surface area was measure to be
8.8 m2/g. The antibacterial assay shows that both MSNP-INH-CONA, and
MSNP-INH has antibacterial activity.

Figure 2. Antibacterial activity of the particles
(50 ug/mL) with Msmeg.

Conclusions and Future Work
MSNP-INH-CONA has lower antibacterial activity than MSNP-INH. For future
work, INH will be quantified on MSNP-NIH-CONA and the assays will be
repeated.

